|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.68 SEK | -2.86% |
|
-44.26% | -82.98% |
| May. 15 | Transcript : Scandion Oncology A/S - Special Call | |
| Mar. 21 | Scandion Oncology Reports Updated Phase II Corist Data, Including Topline Overall Survival | CI |
Scandion Oncology announced that President and CEO Bo Rode Hansen by mutual agreement will leave his position with immediate effect. Johnny Stilou, who has been employed by Scandion as Chief Financial Officer since July 2021, has been appointed acting CEO effective immediately. The process to identify a new permanent CEO has started.
Bo Rode Hansen will also step down as a member of the Board of Directors of Scandion with immediate effect.
| 1st Jan change | Capi. | |
|---|---|---|
| -82.98% | 2.69M | |
| +9.83% | 118B | |
| +10.80% | 106B | |
| -10.84% | 23.4B | |
| -1.69% | 22.1B | |
| -10.23% | 18.34B | |
| -41.92% | 16.59B | |
| -15.11% | 15.97B | |
| +6.62% | 14.03B | |
| +17.53% | 11.67B |
SCANDION ONCOLOGY A/S 
